OBJECTIVE: To determine the gene expression profile of pelvic ganglia neurones after bilateral cavernosal nerve resection (BCNR) and subsequent treatment with sildenafil in relation to neurotrophic-related pathways. MATERIALS AND METHODS: Fisher rats aged 5 months were subjected to BCNR or sham operation and treated with or without sildenafil (20 mg/kg body-weight in drinking water) for 7 days. Total RNA isolated from pelvic ganglia was subjected to reverse transcription and then to quantitative reverse transcriptase-polymerase chain reaction (PCR) with the RAT-neurotrophic array. Results were corroborated by real-time PCR and western blotting. Another set of animals were injected with a fluorescent tracer at the base of the penis, 7 days before BCNR or sham operation, and were sacrificed 7 days after surgery. Sections of pelvic ganglia were used for immunohistochemistry with antibodies against neurturin, neuronal nitric oxide synthase, tyrosine hydroxylase and glial cell line-derived neurotrophic factor receptor α2. RESULTS: A down-regulation of the expression of neuronal nitric oxide synthase accompanied by changes in the level of cholinergic neurotrophic factors, such as neurturin and its receptor glial cell line-derived neurotrophic factor receptor α2, artemin, neurotrophin-4 and cilliary neurotrophic factor, was observed 7 days after BCNR in pelvic ganglia neurones. Treatment with sildenafil, starting immediately after surgery, reversed all these changes at a level similar to that in sham-operated animals. CONCLUSIONS: Sildenafil treatment promotes changes in the neurotrophic phenotype, leading to a regenerative state of pelvic ganglia neurones. The present study provides a justification for the use of phosphodiesterase 5 inhibitors as a neuroprotective agent after BCNR.
OBJECTIVE: To determine the gene expression profile of pelvic ganglia neurones after bilateral cavernosal nerve resection (BCNR) and subsequent treatment with sildenafil in relation to neurotrophic-related pathways. MATERIALS AND METHODS: Fisher rats aged 5 months were subjected to BCNR or sham operation and treated with or without sildenafil (20 mg/kg body-weight in drinking water) for 7 days. Total RNA isolated from pelvic ganglia was subjected to reverse transcription and then to quantitative reverse transcriptase-polymerase chain reaction (PCR) with the RAT-neurotrophic array. Results were corroborated by real-time PCR and western blotting. Another set of animals were injected with a fluorescent tracer at the base of the penis, 7 days before BCNR or sham operation, and were sacrificed 7 days after surgery. Sections of pelvic ganglia were used for immunohistochemistry with antibodies against neurturin, neuronal nitric oxide synthase, tyrosine hydroxylase and glial cell line-derived neurotrophic factor receptor α2. RESULTS: A down-regulation of the expression of neuronal nitric oxide synthase accompanied by changes in the level of cholinergic neurotrophic factors, such as neurturin and its receptor glial cell line-derived neurotrophic factor receptor α2, artemin, neurotrophin-4 and cilliary neurotrophic factor, was observed 7 days after BCNR in pelvic ganglia neurones. Treatment with sildenafil, starting immediately after surgery, reversed all these changes at a level similar to that in sham-operated animals. CONCLUSIONS:Sildenafil treatment promotes changes in the neurotrophic phenotype, leading to a regenerative state of pelvic ganglia neurones. The present study provides a justification for the use of phosphodiesterase 5 inhibitors as a neuroprotective agent after BCNR.
Authors: J P Golden; R H Baloh; P T Kotzbauer; P A Lampe; P A Osborne; J Milbrandt; E M Johnson Journal: J Comp Neurol Date: 1998-08-17 Impact factor: 3.215
Authors: Monica G Ferrini; Istvan Kovanecz; Sandra Sanchez; Chiome Umeh; Jacob Rajfer; Nestor F Gonzalez-Cadavid Journal: J Sex Med Date: 2008-12-02 Impact factor: 3.802
Authors: Ryan Dobbs; Elizabeth Kalmanek; Shawn Choe; Daniel A Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Exp Neurol Date: 2018-11-02 Impact factor: 5.330
Authors: Shawn Choe; Christopher W Bond; Daniel A Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Nanomedicine Date: 2016-09-06 Impact factor: 5.307
Authors: Leah A Garcia; Su M Hlaing; Richard A Gutierrez; Maria D Sanchez; Istvan Kovanecz; Jorge N Artaza; Monica G Ferrini Journal: Int J Mol Sci Date: 2014-09-26 Impact factor: 5.923
Authors: Giorgio Gandaglia; Nazareno Suardi; Vito Cucchiara; Marco Bianchi; Shahrokh F Shariat; Morgan Roupret; Andrea Salonia; Francesco Montorsi; Alberto Briganti Journal: Transl Androl Urol Date: 2015-04